ReviewCurrent diabetes reports2022

Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.

Jason A Zehden et al.PubMed ↗Publisher ↗

No numbers read from the abstract.